SLS Sellas Life Sciences Group Inc
Company Analysis
Latest News
Sellas Life Sciences Surges 58% in a Week on Buyout Whispers and a Looming Cancer Trial Verdict — But Is the Market Pricing in a Miracle?
Shares of Sellas Life Sciences shifted sharply higher this week, with the stock rocketing from $8.53 to $13.47 — a 58% gain in five sessions — as two powerful...
🟢 SLS is trading 8.8% up today on buyout speculation and imminent Phase 3 REGAL trial data
SLS is trading 8.8% up at $13.47, extending a sharp multi-session rally as the market anticipates pivotal clinical results. • The price action is driven by...
🟢 SLS surges 5.65% amid buyout speculation and imminent clinical trial readout
• SLS stock is up 5.65% today, driven by heightened speculation of a potential company buyout following recent executive compensation amendments. • Investors...
SELLAS Life Sciences Secures $135.8M Cash, Extending Runway Past Two Years
SELLAS Life Sciences reported a pro forma cash position of approximately $135.8 million as of early June. Recent warrant exercises significantly bolstered this...
🟢 SLS makes sharp 10.3% jump
SLS is trading at $11.61, up 10.3% versus the comparison close of $10.53 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 SLS is trading 6.9% up today as executive contract changes fuel M&A speculation
SLS is trading 6.9% up now at $11.26 after investors react to newly amended executive employment and severance agreements that shift change-of-control benefits...
SELLAS Life Sciences Amends Executive Severance and Change of Control Agreements
SELLAS Life Sciences Group has entered into amended employment and severance agreements with its President and CEO, Dr. Angelos Stergiou; CFO, John Burns; and...
🟢 SLS makes sharp 10.9% jump
SLS is trading at $10.17, up 10.9% versus the comparison close of $9.17 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 SLS is trading 5.5% up today as traders position for Phase 3 REGAL trial results
SLS is trading 5.5% up today at $9.67 as traders continue positioning around binary Phase 3 REGAL trial results and elevated volatility typical for pre-readout...
🟢 SLS is trading 6.8% up today, extending a multi-day rally on momentum
SLS is trading 6.8% up at $9.11 today, extending a sharp multi-day rally despite a lack of fresh company-specific catalysts. • The stock has climbed...
SLS Shareholders Approve 20M Share Increase to Equity Plan at Annual Meeting
SELLAS Life Sciences Group, Inc. announced the voting results from its Annual Meeting of Stockholders held on June 16, 2026. All five proposals were approved...
🟢 Sellas Life Sciences Group Inc surges 5.6% following $154.6M shelf filing and increased borrow rates
- Sellas Life Sciences Group Inc. has filed a $154.6 million shelf registration for up to 20,000,000 common shares, signaling future capital raising for its...